Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore MD 21201, USA.
J Subst Abuse Treat. 2011 Dec;41(4):431-9. doi: 10.1016/j.jsat.2011.06.005. Epub 2011 Aug 6.
Waiting lists for methadone treatment have existed in many U.S. communities, but little is known nationally about what patient and service system factors are related to admission delays that stem from program capacity shortfalls. Using a combination of national data sources, this study examined patterns in capacity-related admission delays to outpatient methadone treatment in 40 U.S. metropolitan areas (N = 28,920). Patient characteristics associated with admission delays included racial/ethnic minority status, lower education, criminal justice referral, prior treatment experience, secondary cocaine or alcohol use, and co-occurring psychiatric problems. Injection drug users experienced fewer delays, as did self-pay patients and referrals from health care and addiction treatment providers. Higher community-level utilization of methadone treatment was associated with delay, whereas delays were less common in communities with higher utilization of alternative modalities. These findings highlight potential disparities in timely admission to outpatient methadone treatment. Implications for improving treatment access and service system monitoring are discussed.
等候接受美沙酮治疗的名单在美国的许多社区都存在,但全国范围内对于哪些患者和服务系统因素与因项目能力不足而导致的入院延迟有关知之甚少。本研究结合了国家数据源,考察了 40 个美国大都市地区门诊美沙酮治疗相关入院延迟的模式(N=28920)。与入院延迟相关的患者特征包括种族/民族少数群体地位、教育程度较低、刑事司法转介、既往治疗经验、次要可卡因或酒精使用以及同时存在的精神健康问题。注射吸毒者的延迟时间较少,自付患者和来自医疗保健和成瘾治疗提供者的转介也是如此。较高的社区层面的美沙酮治疗利用率与延迟相关,而在替代模式利用率较高的社区,延迟的情况则不太常见。这些发现突出了门诊美沙酮治疗及时入院方面的潜在差异。讨论了改善治疗机会和服务系统监测的意义。